ARTICLE: Colloidal Oatmeal Part II: Atopic Dermatitis in Special Populations and Clinical Efficacy and Tolerance Beyond Eczema

Authors

Blair Allais
Adam Friedman

Document Type

Journal Article

Publication Date

10-1-2020

Journal

Journal of drugs in dermatology : JDD

Volume

19

Issue

10

Abstract

Colloidal oatmeal has a diverse array of applications, clinical benefits, and uses beyond atopic dermatitis. First and foremost, it has been shown to be of benefit in the treatment of atopic dermatitis in skin of color. It has also been shown to be of benefit in the treatment of hand dermatitis, xerosis, psoriasis, skin manifestations of diabetes, and in the treatment of cutaneous adverse effects associated with oncologic therapies. In Part II of this 2-part series, we examine the efficacy, safety, and expansive clinical applications of colloidal oatmeal. J Drugs Dermatol. 2020;19:10(Suppl):s8-11.

APA Citation

Allais, B., & Friedman, A. (2020). ARTICLE: Colloidal Oatmeal Part II: Atopic Dermatitis in Special Populations and Clinical Efficacy and Tolerance Beyond Eczema. Journal of drugs in dermatology : JDD, 19 (10). Retrieved from https://hsrc.himmelfarb.gwu.edu/smhs_derm_facpubs/458